U-Neuron Biomedical (ROCO:6973) Net Margin %: -74.73% (As of Dec. 2025)


ROCO:6973 U-Neuron Biomedical Inc ROCO:6973
12 GF Score
Price NT$33.75
! 2 Warning Signs
View Full Analysis

What is U-Neuron Biomedical Net Margin %?

U-Neuron Biomedical ROCO:6973 12 Net Margin % is -74.73% as of Dec. 2025. GuruFocus rates ROCO:6973 with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 941 Biotechnology companies, U-Neuron Biomedical ranks better than 52.18% on this metric.

Net margin is calculated as Net Income divided by its Revenue. U-Neuron Biomedical's Net Income for the six months ended in Dec. 2025 was NT$-31.82 Mil. U-Neuron Biomedical's Revenue for the six months ended in Dec. 2025 was NT$42.58 Mil. Therefore, U-Neuron Biomedical's net margin for the quarter that ended in Dec. 2025 was -74.73%.

The historical rank and industry rank for U-Neuron Biomedical's Net Margin % or its related term are showing as below:

ROCO:6973' s Net Margin % Range Over the Past 10 Years
Min: -314.14   Med: -129.77   Max: -39.62
Current: -66.89

ROCO:6973's Net Margin % is ranked better than
52.18% of 941 companies
in the Biotechnology industry
Industry Median: -88.29 vs ROCO:6973: -66.89

U-Neuron Biomedical  (ROCO:6973) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

U-Neuron Biomedical Net Margin % Related Terms

U-Neuron Biomedical Net Margin % Historical Data

* Premium members only.

The historical data trend for U-Neuron Biomedical's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical Net Margin % Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial -39.62 -161.15 -314.14 -129.77 -66.89

U-Neuron Biomedical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -191.85 -155.48 -108.73 -58.56 -74.73

ROCO:6973 vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, U-Neuron Biomedical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

U-Neuron Biomedical Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's Net Margin % distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's Net Margin % falls into.


ROCO:6973
12GF Score
U-Neuron Biomedical Inc ROCO:6973
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

U-Neuron Biomedical Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

U-Neuron Biomedical's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-55.294/82.663
=-66.89 %

U-Neuron Biomedical's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-31.819/42.579
=-74.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -74.73% mean?
U-Neuron Biomedical (ROCO:6973) has a Net Margin % of -74.73% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on U-Neuron Biomedical and its competitors. According to the industry distribution chart, U-Neuron Biomedical ranks #450 out of 941 companies in the Biotechnology industry, placing it in the top 47.8%.
Is U-Neuron Biomedical's Net Margin % too high?
U-Neuron Biomedical's current Net Margin % is -74.73%. Based on the distribution chart, U-Neuron Biomedical ranks #450 out of 941 companies in the Biotechnology industry, which is above the industry midpoint. Overall, U-Neuron Biomedical has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does U-Neuron Biomedical's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, U-Neuron Biomedical ranks #450 out of 941 companies for Net Margin %. This puts U-Neuron Biomedical in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on U-Neuron Biomedical and its competitors. U-Neuron Biomedical's current Net Margin % is -74.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is U-Neuron Biomedical stock overvalued right now?
U-Neuron Biomedical (ROCO:6973) has a current Net Margin % of -74.73%. The current Net Margin % is -74.73%. U-Neuron Biomedical's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For U-Neuron Biomedical (ROCO:6973), the current Net Margin % is -74.73% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

U-Neuron Biomedical Business Description

Address Xintai 5th Road, 18th Floor-5, No. 99, Section. 1, Xizhi District, New Taipei City, TWN, 22175
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.
12GF Score

Get the complete analysis for ROCO:6973

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$33.75
Price